1) fluoroquinolone antibiotics
喹诺酮类抗菌药物
1.
2,3,4,5-Tetrafluorobenzoic acid(TFBA),an important intermediates of fluoroquinolone antibiotics,was prepared starting from Nphenyl tetrachlorophthalimide,which reacted with potassium fluoride in the presence of DMF and hexadecyltributylammonium bromide at 140～150℃ for 7～9 h to give N-phenyl tetrafluorophthalimide(PTFP) in 87% yield.
以N-苯基-四氯邻苯二甲酰亚胺(PDPA)为起始原料,合成了第三代喹诺酮类抗菌药物的重要中间体2,3,4,5-四氟苯甲酸(TFBA)。
2) Fluoroquinolones
氟喹诺酮类抗菌药物
1.
These new fluoroquinolones provide more choice for clinical doctors to treat infection patients, but we should use these fluoroquinolones reasonably in order to avoide bacteria resistance producing and the interaction between drugs.
为避免细菌耐药性产生,及药物间相互作用,本文对如何合理应用氟喹诺酮类抗菌药物及临床用药特点做一综述。
4) Fluoroquinolones
氟喹诺酮类抗菌药
1.
Progress about Drug Fast Mechanism of Enterococcus to Fluoroquinolones;
肠球菌对氟喹诺酮类抗菌药物耐药机制研究进展
5) Quinolones
喹诺酮类药物
1.
On-line Sweeping Determination of Quinolones in Pork Tissue by Micellar Capillary Electrophoresis;
胶束毛细管电泳在线推扫技术分离检测猪肉组织中痕量喹诺酮类药物
2.
Study for Spectral Performance of Seven Quinolones;
7种喹诺酮类药物的光谱研究
3.
Cost-Effectiveness Analysis of Three Quinolones for Respiratory Tract Infection;
3种喹诺酮类药物治疗上呼吸道感染成本-效果分析
6) fluoroquinolone
氟喹诺酮类药物
1.
The Susceptibility of Ureaplasma Urealyticum to Fluoroquinolones;
解脲脲原体临床株对氟喹诺酮类药物的敏感性研究
2.
Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites;
解脲脲原体耐氟喹诺酮类药物突变体的分离及其突变位点的研究(英文)
3.
Objective:To explore the role of efflux pump in drug resistance to fluoroquinolones in Stenotrophomonas maltophilia.
目的:探讨主动外排泵在嗜麦芽寡养单胞菌对氟喹诺酮类药物耐药中的作用。
补充资料：泛喹酮
分子式：
CAS号：
性质：又名安痢平。橙红色结晶粉末，无臭，味微苦。微溶于水，不溶于乙醇及氯仿。由邻氨基苯甲醚为原料制得。对溶组织阿米巴滋养体、肠梨形虫、滴虫及革兰阴性杆菌等都有抑制作用。可用于急、慢性阿米巴痢。制剂为片剂。
CAS号：
性质：又名安痢平。橙红色结晶粉末，无臭，味微苦。微溶于水，不溶于乙醇及氯仿。由邻氨基苯甲醚为原料制得。对溶组织阿米巴滋养体、肠梨形虫、滴虫及革兰阴性杆菌等都有抑制作用。可用于急、慢性阿米巴痢。制剂为片剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条